- Conditions
- Adult Idiopathic Generalized Osteoporosis
- Interventions
- Teriparatide, Saline Placebo
- Drug
- Lead sponsor
- Elizabeth Shane
- Other
- Eligibility
- 20 Years to 45 Years · Female only
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2019
- U.S. locations
- 2
- States / cities
- Omaha, Nebraska • New York, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Premenopausal Idiopathic Osteoporosis
- Interventions
- Romosozumab Prefilled Syringe [Evenity], Denosumab 60 MG/ML Prefilled Syringe [Prolia]
- Drug
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2028
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Adult Idiopathic Generalized Osteoporosis
- Interventions
- Denosumab
- Drug
- Lead sponsor
- Elizabeth Shane
- Other
- Eligibility
- 20 Years to 50 Years · Female only
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2021
- U.S. locations
- 2
- States / cities
- Omaha, Nebraska • New York, New York
- Conditions
- Menopause, Fracture, Osteoporosis
- Interventions
- Teriparatide (PTH 1-34)
- Drug
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 20 Years to 48 Years · Female only
- Enrollment
- 22 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2012
- U.S. locations
- 2
- States / cities
- Omaha, Nebraska • New York, New York
- Conditions
- IOP, Osteoporosis
- Interventions
- Alendronate, Zoledronic Acid
- Drug
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 20 Years to 55 Years · Female only
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 2
- States / cities
- Omaha, Nebraska • New York, New York